We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Liquid Biopsy Helps Identify Emerging Drug Resistance in Prostate Cancer

News   Aug 13, 2018 | Original story sourced from the London Institute of Cancer Research

 
New Prostate Cancer Blood Test Detects Early Treatment Failure

Prostate cancer cells. The development of new liquid biopsies reduces the need for traditional invasive biopsies. Credit: Mateus Crespo, Ana Ferreira, Daniel Nava Rodrigues and Johann de Bono.

 
 
 

RELATED ARTICLES

Whole Genome Sequencing for Personalized Antibiotic Therapy

News

Researchers have added to evidence that rapid resistance gene sequencing technology can accurately speed the identification of specific antibiotic-resistant bacteria strains that sicken and kill some patients.

READ MORE

New Biomarkers Detect 70% of Pancreatic Cancer, a Vast Improvement

News

A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and difficult-to treat stages.

READ MORE

World Trade Center Responders at Increased Risk of Head and Neck Cancers

News

The study, which is the first to report on head and neck cancers in World Trade Center first responders, found a 40 percent increase in diagnosis of these diseases between 2009 and 2012.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE